Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.

BACKGROUND The antifungal activity of some popular analgesic drugs was postulated by several authors. OBJECTIVES The aim of this study was to verify the antifungal effectiveness of acetylsalicylic acid, ibuprofen, metamizole, meloxicam and paracetamol against triazole-susceptible and triazole-resistant Candida spp isolates. METHODS The minimal inhibitory concentration as well as fractional inhibitory concentration of selected analgesics and triazole on eighteen Candida spp isolates were determined by the standard microdilution method according to EUCAST. RESULTS Among five tested compounds, only ibuprofen showed an antifungal effect against all tested isolates. In combination tests of analgesics with triazole, three types of interaction have been observed: indifference, synergism and antagonism. An azole-resistant strain of C. albicans demonstrated synergism with IBU and each of the 5 tested azole. Posaconazole also demonstrated synergism with IBU in two other cases, namely a C. albicans strain and with C. glabrata, which were both azole-resistant. Combination of FLU and IBU in two cases resulted in antagonism: in experiments with C. glabrata and C. tropicalis. This interaction was also observed when metamizole and fluconazole were used in combination on C. krusei. CONCLUSIONS The results obtained by us confirmed antifungal activity of ibuprofen, what support purposefulness to continue the study on antimicrobial activity of this group of drugs.

• Publication year

  2018

• Venue

  Journal de Mycologie Médicale

• Publication date

  2018-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.mycmed.2018.03.002PMID 29605543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species

  2017cited by this paper
• Pharmacokinetic and pharmacodynamic evaluation according to absorption differences in three formulations of ibuprofen

  2017cited by this paper
• The development of fluconazole resistance in Candida albicans – an example of microevolution of a fungal pathogen

  2016cited by this paper
• Global Identification of Biofilm-Specific Proteolysis in Candida albicans

  2016cited by this paper
• Role of a NSAID in the apparent cure of a fungal mycetoma.

  2016cited by this paper
• Isolation and identification of Candida species in patients with orogastric cancer: susceptibility to antifungal drugs, attributes of virulence in vitro and immune response phenotype

  2016cited by this paper
• Ibuprofen-mediated reversal of fluconazole resistance in clinical isolates of Candida.

  2015cited by this paper
• Antifungal drug resistance among Candida species: mechanisms and clinical impact

  2015cited by this paper
• Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors.

  2012cited by this paper
• Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata

  2012cited by this paper
• EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST).

  2012cited by this paper
• Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007)

  2009cited by this paper
• Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.

  2009cited by this paper
• In vitro and in vivo therapeutic activity of ibuprofen against dermatophytes.

  2009cited by this paper
• The conventional identification and effect of diclofenac and aspirin on the Candida species

  2009cited by this paper
• Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry.

  2005cited by this paper
• Reassessment of the in vitro synergistic effect of fluconazole with the non‐steroidal anti‐inflammatory agent ibuprofen against Candida albicans

  2005cited by this paper
• Effects of Aspirin and Other Nonsteroidal Anti-Inflammatory Drugs on Biofilms and Planktonic Cells of Candida albicans

  2004cited by this paper
• In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against Clinical Scedosporium prolificans Isolates

  2003cited by this paper
• Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species.

  2000cited by this paper

• Simultaneous Eco-Friendly Spectrofluorometric Estimation of Itraconazole and Ibuprofen in Pharmaceutical and Biological Matrices.

  2025cites this paper
• Fluorophenyl-1,2,4-Triazole Derivatives: Synthesis, Structural Analysis, Chemotype Clustering and Antimicrobial Screening

  2025cites this paper
• The mechanism research of itraconazole combined with aspirin in the treatment of vulvovaginal candidiasis through NF-κB signaling pathway

  2024cites this paper
• DEVELOPMENT OF A COMBINATION TABLET TO TACKLE THE DRUG RESISTANCE OF ORAL CANDIDIASIS

  2024cites this paper
• Ibuprofen as an adjuvant to conventional antimicrobials and essential oil compounds against skin pathogens.

  2024cites this paper
• Can nonsteroidal anti-inflammatory drugs (NSAIDs) be repurposed for fungal infection?

  2023cites this paper
• Pluronic F-127 Enhances the Antifungal Activity of Fluconazole against Resistant Candida Strains

  2023cites this paper
• Synergistic effect of hydralazine associated with triazoles on Candida spp. in planktonic cells.

  2023cites this paper
• In vitro antifungal and antibiofilm activities of novel sulfonyl hydrazone derivatives against Candida spp.

  2022cites this paper
• Novel avenues for identification of new antifungal drugs and current challenges

  2022cites this paper
• Pharmacokinetics and Pharmacodynamics of Ibrexafungerp

  2021cites this paper
• Cotreatment with Aspirin and Azole Drugs Increases Sensitivity of Candida albicans in vitro

  2021cites this paper
• Design, synthesis and biological evaluation of a series of iron and copper chelating deferiprone derivatives as new agents active against Candida albicans.

  2021cites this paper
• Anti-Sporothrix activity of ibuprofen combined with antifungal

  2020cites this paper
• Antifungal Drug Repurposing

  2020cites this paper
• In silico validation of non-antibiotic drugs, acetaminophen and ibuprofen as antibacterial agents against red complex pathogens.

  2019cites this paper
• Indifferent effect of nonsteroidal anti-inflammatory drugs (NSAIDs) combined with fluconazole against multidrug-resistant Candida auris

  2019cites this paper
• Actividad antifúngica de la combinación de fluconazol con otros fármacos: un enfoque terapéutico alternativo de las candidiasis

  2018influential citation